Methscopolamine - NDC Database

17 records found
Page:1
0168-0482 image
0168-0482 Mar 16, 2011
Methscopolamine 2.5 mg Oral Tablet by E. Fougera & Co. a Division of Fougera Pharmaceuticals Inc.
64376-603 image
64376-603 Dec 28, 2006
Methscopolamine 2.5 mg Oral Tablet by Boca Pharmacal, LLC
64376-604 image
64376-604 Dec 28, 2006
Methscopolamine 5 mg Oral Tablet by Boca Pharmacal, LLC
0168-0483 Jul 27, 2011
Methscopolamine 5 mg Oral Tablet by E. Fougera & Co. a Division of Fougera Pharmaceuticals Inc.
18754-061 Oct 22, 2009
Methscopolamine 2.5 mg Oral Tablet by A. Aarons
18754-062 Oct 22, 2009
Methscopolamine 5 mg Oral Tablet by A. Aarons
43063-740 Oct 01, 2013
Methscopolamine Bromide 2.5 mg Oral Tablet by Pd-rx Pharmaceuticals, Inc.
43063-741 Oct 01, 2013
Methscopolamine Bromide 5 mg Oral Tablet by Pd-rx Pharmaceuticals, Inc.
51991-191 May 21, 2012
Methscopolamine 2.5 mg Oral Tablet by Breckenridge Pharmaceutical, Inc.
51991-192 May 21, 2012
Methscopolamine 5 mg Oral Tablet by Breckenridge Pharmaceutical, Inc.
60429-251 Dec 28, 2006
Methscopolamine 5 mg Oral Tablet by Golden State Medical Supply, Inc.
71406-126 Feb 05, 2024
Methscopolamine Bromide 2.5 mg Oral Tablet by Aace Pharmaceuticals, Inc.
71406-127 Feb 05, 2024
Methscopolamine Bromide 5 mg Oral Tablet by Aace Pharmaceuticals, Inc.
76385-100 Oct 01, 2013
Methscopolamine 2.5 mg Oral Tablet by Bayshore Pharmaceuticals LLC
76385-101 Oct 01, 2013
Methscopolamine 5 mg Oral Tablet by Bayshore Pharmaceuticals LLC
81005-127 Feb 26, 2024
Methscopolamine Bromide 2.5 mg Oral Tablet by Aarkish Pharmaceuticals Nj Inc.
81005-128 Feb 26, 2024
Methscopolamine Bromide 5 mg Oral Tablet by Aarkish Pharmaceuticals Nj Inc.
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.